| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | 4-Aminopyridine | FAERS: 5 | US FAERS | |
| 2 | Dabigatran | FAERS: 1 | US FAERS | |
| 3 | Deferasirox | FAERS: 1 | US FAERS | |
| 4 | Lenalidomide | FAERS: 1 | US FAERS | |
| 5 | Nexium 24hr | FAERS: 1 | US FAERS | |
| 6 | Omeprazole | FAERS: 1 | US FAERS | |
| 7 | Omeprazole | FAERS: 1 | US FAERS | |
| 8 | Pemetrexed | FAERS: 1 | OFFSIDES US FAERS | |
| 9 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 10 | Teriparatide | FAERS: 1 | US FAERS | |
| 11 | Thalidomide | FAERS: 1 | US FAERS | |
| 12 | Valsartan | FAERS: 1 | US FAERS | |
| 13 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 14 | Etoricoxib | OFFSIDES | ||
| 15 | Tolterodine Tartrate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.